GlassScriptPhysician profile
Stephanie Mayes
NPI 1366633620
$1,496.85
in general payments reported to CMS, 2019-2025
21 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $77.35 · 2021: $70.93 · 2022: $158 · 2023: $354 · 2024: $329 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.21 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.91 | 2019-2025 | |
| Minerva Surgical, INC | $212.51 | 2019 | |
| Coopersurgical, INC. | $154.88 | 2019-2024 | Paragard T 380a, Summit Doppler |
| Mayne Pharma Commercial LLC | $118.61 | 2022-2024 | |
| Pfizer INC. | $100.00 | 2023 | |
| Biogen, INC. | $74.94 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $73.65 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $72.92 | 2023-2024 | Fluent Fluid Management System, Aptima, Myosure Tissue Removal Device |
| Organon LLC | $70.63 | 2022-2024 | Nexplanon |
| Therapeuticsmd, INC. | $54.29 | 2019-2020 | |
| Myriad Women'S Health, INC. | $53.22 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.01 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $34.93 | 2023-2025 | Gardasil 9 |
| Exact Sciences Corporation | $31.74 | 2024-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $27.45 | 2024 | Solyx Sis System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $22.15 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $21.61 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Millicent US INC | $14.10 | 2020 | |
| Exeltis, USA INC. | $12.49 | 2022 | |
| Allergan, INC. | $12.41 | 2020 | |
| Daiichi Sankyo INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Mayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.